September 10, 2022

SpringWorks Therapeutics Announces Data from Phase 3 DeFi Trial Evaluating Nirogacestat in Adult Patients with Progressing Desmoid… Nirogacestat Treatment: A Game-Changer in Desmoid Tumor Management SpringWorks Therapeutics has recently shared exciting news regarding the results of their Phase 3 DeFi Trial evaluating the efficacy of Nirogacestat in adult patients with progressing desmoid tumors. The data…

ROSEN, A TOP RANKED LAW FIRM, Encourages Coupang, Inc. Investors to Secure Counsel Before Important Deadline Overview NEW YORK, Sept. 09, 2022 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Coupang, Inc. (NYSE: CPNG) pursuant and/or traceable to the registration statement and related prospectus issued…